These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1792811

  • 1. [Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study].
    Assmann I, Kassel P, Duck HG, Fiehring H, Morgan P, Schmidt PK, Höfs T, Nehmiz G.
    Z Kardiol; 1991 Nov; 80(11):687-94. PubMed ID: 1792811
    [Abstract] [Full Text] [Related]

  • 2. [Pimobendan (UDCG 115 BS) in long-term therapy of chronic heart failure].
    Bergler-Klein J, Globits S, Stefenelli T, Mayr H, Porenta G, Sochor H, Glogar D.
    Z Kardiol; 1992 Oct; 81(10):546-52. PubMed ID: 1441695
    [Abstract] [Full Text] [Related]

  • 3. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
    Hauf GF, Grom E, Jähnchen E, Roskamm H.
    J Cardiovasc Pharmacol; 1989 Oct; 14 Suppl 2():S49-56. PubMed ID: 2478793
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G, Ningel K, Permanetter B.
    J Cardiovasc Pharmacol; 1989 Oct; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlations between the cardiovascular effects of pimobendan and plasma concentrations of the parent compound and of its major active metabolite, UD-CG 212 CL, in patients with congestive heart failure.
    Hagemeijer F, Roth W, Brand HJ.
    J Cardiovasc Pharmacol; 1989 Oct; 14 Suppl 2():S57-64. PubMed ID: 2478794
    [Abstract] [Full Text] [Related]

  • 10. [Acute and chronic effects of UDCG 115 BS (pimobendan) in patients with advanced myocardial failure].
    Permanetter B, Baumann G, Wirtzfeld A, Günes S, Stinshoff M, Klein G.
    Z Kardiol; 1989 May; 78(5):335-42. PubMed ID: 2660451
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of long-term treatment with pimobendan on neurohumoral factors in patients with non-ischemic chronic moderate heart failure.
    Sasaki T, Kubo T, Komamura K, Nishikimi T.
    J Cardiol; 1999 Jun; 33(6):317-25. PubMed ID: 10396705
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Ibopamine in the treatment of congestive heart failure. Multicenter follow-up study].
    Fonseca C, Gouveia R, Ceia F, Mota E, Coelho EM, Gil V, Riva E, Astorga MA, Gomes RS, Luís AS.
    Rev Port Cardiol; 1992 Jun; 11(6):515-23. PubMed ID: 1503784
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.